COMMUNIQUÉS West-GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
22/05/2026 -
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
22/05/2026 -
XTL Announces Receipt of Staff Delist Determination from Nasdaq
22/05/2026 -
GlycoPulse Claims Evaluated: Most Advanced Blood Sugar Support Ingredients for Healthy Glucose Management by Glyco Pulse
22/05/2026 -
Calidi Biotherapeutics Provides Required NYSE American Disclosure
23/05/2026 -
Organifi Parasite Cleanse Kit: The Most Effective Herbal Parasite Binding Detox Supplements on the Market
23/05/2026 -
Slim Tide Under Investigation: Critical Research Details Ingredients' Effectiveness for Metabolic & Digestive Support
23/05/2026 -
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
22/05/2026 -
SCYNEXIS Announces One-for-Eight Reverse Stock Split
22/05/2026 -
Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
22/05/2026 -
MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
22/05/2026 -
Vaya Health and Partners Health Management Announce Merger
22/05/2026 -
Guerbet : Evolution de la composition du Conseil d’administration de Guerbet.
22/05/2026 -
Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)
22/05/2026 -
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
22/05/2026 -
Leo International Precision Health AG approves cash capital increase excluding subscription rights
22/05/2026 -
Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
22/05/2026 -
Regenix Labs Introduces NMN Supplement Designed to Support Cellular Vitality and Healthy Aging
22/05/2026 -
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
22/05/2026
Pages